atorvastatin has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdollahi, A; Akbarian, R; Chamanara, M; Dehpour, AR; Ejtemaei Mehr, S; Rashidian, A | 1 |
| Barut, T; Ekerbiçer, N; Gürpınar, T; Harzadın, NU; Tarakçı, F; Tuglu, MI | 1 |
| Alavi, KH; Assadi, AR; Damavandi, M; Shafiee, K; Zangiabadi, N | 1 |
| Bell, DS; Vaughan, TB | 1 |
2 trial(s) available for atorvastatin and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Atorvastatin treatment improves diabetic polyneuropathy electrophysiological changes in non-insulin dependent diabetic patients: a double blind, randomized clinical trial.
Topics: Animals; Atorvastatin; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Double-Blind Method; Electrophysiology; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neural Conduction; Pyrroles; Rats; Tibial Nerve | 2012 |
The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia.
Topics: Anticholesteremic Agents; Apolipoproteins B; Atorvastatin; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Dose-Response Relationship, Drug; Double-Blind Method; Fatty Acids, Nonesterified; Female; Heptanoic Acids; Humans; Hyperlipidemias; Lipoprotein Lipase; Lipoproteins; Male; Middle Aged; Placebos; Pyrroles; Time Factors; Triglycerides | 2001 |
3 other study(ies) available for atorvastatin and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Atorvastatin prevents the development of diabetic neuropathic nociception by possible involvement of nitrergic system.
Topics: Animals; Atorvastatin; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nociception; Rats; Streptozocin | 2021 |
Statin treatment reduces oxidative stress-associated apoptosis of sciatic nerve in diabetes mellitus.
Topics: Animals; Apoptosis; Atorvastatin; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Nitric Oxide Synthase; Oxidative Stress; Pyrroles; Rats; Rats, Wistar; Sciatic Nerve; Streptozocin; Transforming Growth Factor beta1 | 2011 |
Statin neuropathy masquerading as diabetic autoimmune polyneuropathy.
Topics: Adolescent; Anticholesteremic Agents; Atorvastatin; Autoimmunity; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; Heptanoic Acids; Humans; Pyrroles; Restless Legs Syndrome | 2005 |